Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note issued on Sunday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright decreased their price target on shares of Aethlon Medical from $90.00 to $23.00 and set a “buy” rating on the stock in a report on Tuesday, October 24th.

Aethlon Medical Trading Down 7.0 %

Shares of Aethlon Medical stock opened at $1.72 on Friday. The firm has a market capitalization of $4.27 million, a PE ratio of -0.32 and a beta of 1.39. The firm’s 50 day moving average is $2.01 and its 200 day moving average is $2.96. Aethlon Medical has a 1 year low of $1.40 and a 1 year high of $8.70.

Aethlon Medical (NASDAQ:AEMD) last announced its quarterly earnings results on Thursday, August 10th. The medical equipment provider reported ($1.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.20) by ($0.10). During the same quarter in the prior year, the company earned ($1.90) EPS. As a group, research analysts anticipate that Aethlon Medical will post -5.45 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Aethlon Medical by 112.9% in the third quarter. Vanguard Group Inc. now owns 1,053,198 shares of the medical equipment provider’s stock valued at $613,000 after purchasing an additional 558,596 shares during the last quarter. Renaissance Technologies LLC increased its holdings in Aethlon Medical by 11.6% during the first quarter. Renaissance Technologies LLC now owns 270,297 shares of the medical equipment provider’s stock worth $395,000 after buying an additional 28,097 shares during the last quarter. Jane Street Group LLC increased its holdings in Aethlon Medical by 895.7% during the fourth quarter. Jane Street Group LLC now owns 140,245 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 126,160 shares during the last quarter. Two Sigma Investments LP increased its holdings in Aethlon Medical by 219.3% during the first quarter. Two Sigma Investments LP now owns 127,341 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 87,458 shares during the last quarter. Finally, Citadel Advisors LLC bought a new position in Aethlon Medical during the third quarter worth about $72,000. Institutional investors and hedge funds own 3.02% of the company’s stock.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system.